Molecular classification and subtype-specific characterization of skin cutaneous melanoma by aggregating multiple genomic platform data

[1]  Jiuyong Li,et al.  CancerSubtypes: an R/Bioconductor package for molecular cancer subtype identification, validation and visualization , 2017, Bioinform..

[2]  K. Mertz,et al.  Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome. , 2016, Human pathology.

[3]  H. Kohrt,et al.  Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma. , 2016, The Journal of clinical investigation.

[4]  S. Feldman,et al.  Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. , 2015, JAMA dermatology.

[5]  Steven J. M. Jones,et al.  Genomic Classification of Cutaneous Melanoma , 2015, Cell.

[6]  A. Slominski,et al.  The role of melanin pigment in melanoma , 2015, Experimental dermatology.

[7]  Qing Zhao,et al.  Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA , 2015, Briefings Bioinform..

[8]  E. Bonafede.  Differential expression analysis for sequence count data via mixtures of negative binomials , 2015 .

[9]  Parisha Bhatia,et al.  Impact of BRAF mutation status in the prognosis of cutaneous melanoma: an area of ongoing research. , 2015, Annals of translational medicine.

[10]  R. Martí,et al.  Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma , 2015, BioMed research international.

[11]  G. Malerba,et al.  Association of promoter polymorphism −765G>C in the PTGS2 gene with malignant melanoma in Italian patients and its correlation to gene expression in dermal fibroblasts , 2014, Experimental dermatology.

[12]  Thomas Lengauer,et al.  Comprehensive Analysis of DNA Methylation Data with RnBeads , 2014, Nature Methods.

[13]  Stephen B. Montgomery,et al.  Cis and Trans Effects of Human Genomic Variants on Gene Expression , 2014, PLoS genetics.

[14]  Z. Tu,et al.  Similarity network fusion for aggregating data types on a genomic scale , 2014, Nature Methods.

[15]  Tianshu Li,et al.  Identification of epithelial stromal interaction 1 as a novel effector downstream of Krüppel-like factor 8 in breast cancer invasion and metastasis , 2013, Oncogene.

[16]  A. Heimberger,et al.  Abstract 3251: Blockade of HIF-1 with a small molecule inhibitor WP1066 in melanoma. , 2013 .

[17]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[18]  Yonghong Peng,et al.  A new 12-gene diagnostic biomarker signature of melanoma revealed by integrated microarray analysis , 2013, PeerJ.

[19]  S. Wagner,et al.  Immunotargeting of tumor subpopulations in melanoma patients , 2012, Oncoimmunology.

[20]  P. Ascierto,et al.  Molecular Classification of Patients with Cutaneous Melanoma: A Reality , 2012 .

[21]  R. Scolyer,et al.  Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  R. Scolyer,et al.  Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases , 2012, Modern Pathology.

[23]  V. Joulin,et al.  Ion Channels as Promising Therapeutic Targets for Melanoma , 2011 .

[24]  G. Ghanem,et al.  TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome , 2011, British Journal of Cancer.

[25]  R. Scolyer,et al.  Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care , 2011, Molecular oncology.

[26]  David T. W. Jones,et al.  Oncogenic FAM131B–BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma , 2011, Acta Neuropathologica.

[27]  V. Hearing,et al.  The Roles of ADAMs Family Proteinases in Skin Diseases , 2011, Enzyme research.

[28]  G. Robertson,et al.  Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail. , 2010, Biochemical pharmacology.

[29]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[30]  M. Sormani,et al.  The role of AIRE polymorphisms in melanoma. , 2010, Clinical immunology.

[31]  Johan Staaf,et al.  Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns , 2010, Breast Cancer Research.

[32]  M. Ringnér,et al.  Gene Expression Profiling–Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome , 2010, Clinical Cancer Research.

[33]  R. Stern,et al.  Prevalence of a history of skin cancer in 2007: results of an incidence-based model. , 2010, Archives of dermatology.

[34]  Jeffrey E Gershenwald,et al.  Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  T. Pemberton,et al.  The RTK/RAS/BRAF/PI3K pathways in melanoma: biology, small molecule inhibitors, and potential applications. , 2007, Seminars in oncology.

[36]  L. Fecher,et al.  Toward a molecular classification of melanoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  M. Bally,et al.  Gene silencing in the development of personalized cancer treatment: the targets, the agents and the delivery systems. , 2006, Current gene therapy.

[38]  M. Berwick,et al.  Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. , 2005, Journal of the American Academy of Dermatology.

[39]  H. Aburatani,et al.  Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients , 2005, International journal of cancer.

[40]  Pablo Tamayo,et al.  Metagenes and molecular pattern discovery using matrix factorization , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Mesirov,et al.  Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data , 2003, Machine Learning.

[42]  P. Burkett,et al.  Interleukin-15 and the regulation of lymphoid homeostasis. , 2002, Molecular immunology.

[43]  L. Cornelius,et al.  The role of chemokines in melanoma tumor growth and metastasis. , 2002, The Journal of investigative dermatology.

[44]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  J. J. van den Oord,et al.  Expression of neurotrophins and their receptors in pigment cell lesions of the skin , 2001, The Journal of pathology.

[46]  Gary Lyman,et al.  Age as a prognostic factor in the malignant melanoma population , 1994, Annals of Surgical Oncology.

[47]  C. Balch,et al.  Cutaneous melanoma: prognosis and treatment results worldwide. , 1992, Seminars in surgical oncology.

[48]  P. Rousseeuw.  Silhouettes: a graphical aid to the interpretation and validation of cluster analysis , 1987 .

[49]  W. Clark,et al.  The classification of malignant melanoma and its histologic reporting , 1973, Cancer.

[50]  W. Clark,et al.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.

[51]  K. Honjo,et al.  Emerging roles for the FCRL family members in lymphocyte biology and disease. , 2014, Current topics in microbiology and immunology.

[52]  L. Cannon-Albright,et al.  Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree. , 2013, Journal of dermatological science.

[53]  P. Laird,et al.  Genome-scale analysis of aberrant DNA methylation in colorectal cancer. , 2012, Genome Research.

[54]  Z. Xiong,et al.  Ion channels as targets for cancer therapy. , 2011, International journal of physiology, pathophysiology and pharmacology.

[55]  M. Cahalan,et al.  Ion Channel Phenotype of Melanoma Cell Lines , 1997, The Journal of Membrane Biology.